Peter Barton Hutt - Net Worth and Insider Trading
Peter Barton Hutt Net Worth
The estimated net worth of Peter Barton Hutt is at least $1 Million dollars as of 2024-05-06. Peter Barton Hutt is the Director of Moderna Inc and owns about 3,924 shares of Moderna Inc (MRNA) stock worth over $470,958. Peter Barton Hutt is the Director of Momenta Pharmaceuticals Inc and owns about 6,725 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $352,928. Peter Barton Hutt is also the Director of Concert Pharmaceuticals Inc and owns about 29,488 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $246,815. Details can be seen in Peter Barton Hutt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter Barton Hutt has not made any transactions after 2022-10-14 and currently still holds the listed stock(s).
Transaction Summary of Peter Barton Hutt
Peter Barton Hutt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Barton Hutt owns 11 companies in total, including Concert Pharmaceuticals Inc (CNCE) , Immunomedics Inc (IMMU) , and Moderna Inc (MRNA) among others .
Click here to see the complete history of Peter Barton Hutt’s form 4 insider trades.
Insider Ownership Summary of Peter Barton Hutt
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CNCE | Concert Pharmaceuticals Inc | 2022-10-14 | director |
IMMU | Immunomedics Inc | 2020-10-23 | director |
MRNA | Moderna Inc | 2019-11-20 | director |
2015-01-28 | director | ||
2016-06-21 | director | ||
2014-05-22 | director | ||
2016-08-29 | director | ||
2016-06-15 | director | ||
2014-09-12 | director | ||
2003-07-24 | director & other: Resigned effective 11/5/2003 | ||
2014-05-22 | director |
Peter Barton Hutt Latest Holdings Summary
Peter Barton Hutt currently owns a total of 3 stocks. Among these stocks, Peter Barton Hutt owns 3,924 shares of Moderna Inc (MRNA) as of November 20, 2019, with a value of $470,958 and a weighting of 43.99%. Peter Barton Hutt owns 6,725 shares of Momenta Pharmaceuticals Inc (MNTA) as of September 12, 2014, with a value of $352,928 and a weighting of 32.96%. Peter Barton Hutt also owns 29,488 shares of Concert Pharmaceuticals Inc (CNCE) as of October 14, 2022, with a value of $246,815 and a weighting of 23.05%.
Latest Holdings of Peter Barton Hutt
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MRNA | Moderna Inc | 2019-11-20 | 3,924 | 120.02 | 470,958 |
MNTA | Momenta Pharmaceuticals Inc | 2014-09-12 | 6,725 | 52.48 | 352,928 |
CNCE | Concert Pharmaceuticals Inc | 2022-10-14 | 29,488 | 8.37 | 246,815 |
Holding Weightings of Peter Barton Hutt
Peter Barton Hutt Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Barton Hutt has made a total of 2 transactions in Moderna Inc (MRNA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Moderna Inc is the sale of 200,000 shares on November 20, 2019, which brought Peter Barton Hutt around $4 Million.
According to the SEC Form 4 filings, Peter Barton Hutt has made a total of 0 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years. The most-recent trade in Momenta Pharmaceuticals Inc is the sale of 3,640 shares on September 12, 2014, which brought Peter Barton Hutt around $41,569.
According to the SEC Form 4 filings, Peter Barton Hutt has made a total of 2 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 3,539 shares on October 14, 2022, which brought Peter Barton Hutt around $21,553.
Insider Trading History of Peter Barton Hutt
- 1
Peter Barton Hutt Trading Performance
Peter Barton Hutt Ownership Network
Ownership Network List of Peter Barton Hutt
Ownership Network Relation of Peter Barton Hutt
Peter Barton Hutt Owned Company Details
What does Concert Pharmaceuticals Inc do?
Who are the key executives at Concert Pharmaceuticals Inc?
Peter Barton Hutt is the director of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include Chief Development Officer James V Cassella , CFO & PFO Marc A. Becker , and Chief Operating Officer Nancy Stuart .
Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary
Over the past 18 months, Peter Barton Hutt made no insider transaction in Concert Pharmaceuticals Inc (CNCE). Other recent insider transactions involving Concert Pharmaceuticals Inc (CNCE) include a net sale of 16,093 shares made by Nancy Stuart , a net sale of 12,999 shares made by James V Cassella , and a net sale of 11,386 shares made by Jeffrey A Munsie .
In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 61,104 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 61,104 shares.
Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Concert Pharmaceuticals Inc Insider Transactions
Peter Barton Hutt Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Barton Hutt. Currently GuruFocus does not have mailing address information for Peter Barton Hutt.